N acetyl cysteine
N acetyl cysteine is a pharmaceutical drug with 20 clinical trials. Currently 5 active trials ongoing. Historical success rate of 77.8%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
5
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
77.8%
7 of 9 finished
22.2%
2 ended early
5
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparing N-Acetylcysteine (NAC) Versus Alpha-Lipoic Acid (ALA) as Adjuncts for Postoperative Pain Management After Laparoscopic Appendectomy
N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial
Comparison of the Effects of N-acetylcysteine, Calcium Hydroxide, and Double Antibiotic Paste
Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion
Clinical Trials (20)
Comparing N-Acetylcysteine (NAC) Versus Alpha-Lipoic Acid (ALA) as Adjuncts for Postoperative Pain Management After Laparoscopic Appendectomy
N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial
Comparison of the Effects of N-acetylcysteine, Calcium Hydroxide, and Double Antibiotic Paste
Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion
N-Acetyl Cysteine Effect on Liver Function After Mitral Valve Replacement
FDOPA PET and Nutritional Support in Parkinson's Disease
Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients
Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi
Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis
Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients
The Role of N-acetylcysteine as a Novel Adjuvant Treatment in Acute Organophosphorus Pesticide Poisoning
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial
Intravenous NAC Use in ACLF Patients
N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation.
NAC for Head Trauma-induced Anosmia
Use of NAC in Alleviation of Hangover Symptoms
Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement
N Acetyl Cysteine for Cystinosis Patients
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20